Climb Bio, Inc.
CLYM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001768446
In the last 90 days, Climb Bio, Inc. insiders filed 0 open-market purchases and 1 sale; 108 institutions reported holding it in 13F filings for Q2 2026, worth $734.3M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Climb Bio, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 71 | 80 | +9 |
| Shares | 54.7M | 55.7M | +1.04M (+1.9%) |
| Value | $278.2M | $100.3M | −$177.9M (−64.0%) |
New holders (27)
Institutions that held Climb Bio, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
Sold out (18)
Institutions that held Climb Bio, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Boxer Capital, LLC | 2,603,190 | $13.3M |
| Driehaus Capital Management LLC | 612,387 | $3.12M |
| Point72 Asset Management, L.P. | 590,946 | $3.01M |
| Great Point Partners LLC | 248,168 | $1.26M |
| Monashee Investment Management LLC | 230,000 | $1.17M |
| Millennium Management LLC | 111,137 | $565.7K |
| Acuta Capital Partners, LLC | 54,000 | $274.9K |
| Advantage Alpha Capital Partners LP | 48,169 | $245.2K |
| Winton Group Ltd | 27,551 | $140.2K |
| Dimensional Fund Advisors LP | 18,280 | $93.0K |
| MetLife Investment Management | 17,769 | $90.4K |
| Valence8 US LP | 12,045 | $61.3K |
| Jane Street Group, LLC | 10,907 | $55.5K |
| Advisor Group Holdings, Inc. | 8,333 | $21.7K |
| Quadrant Capital Group LLC | 488 | $2.48K |
| Signaturefd, LLC | 333 | $1.70K |
| US Bancorp | 141 | $718 |
| Russell Investments Group, Ltd. | 69 | $351 |